FluMist Quadrivalent gains tentative approval

TGA approves registration of nasal spray which it says could boost uptake of influenza vaccine While AstraZeneca’s FluMist Quadrivalent influenza virus vaccine nasal spray applicator has been registered on the ARTG since 18 October last year, the medicine has been beset with doubts about its effectiveness—especially compared to the injection. In fact, in July 2016